Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 79 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
NEW PERSPECTIVE
Year : 2020  |  Volume : 10  |  Issue : 2  |  Page : 128-130

Chloroquine: Can it be a Novel Drug for COVID-19


1 Department of Pharmacology; Department of Medical Education, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India
2 Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India

Correspondence Address:
Dinesh Kumar Badyal
Department of Pharmacology, CMCL-FAIMER, Christian Medical College, Ludhiana - 141 008, Punjab
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijabmr.IJABMR_141_20

Rights and Permissions

Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed26015    
    Printed30    
    Emailed0    
    PDF Downloaded589    
    Comments [Add]    

Recommend this journal